S. 3258: Aviation Medication Transparency Act of 2025
The Aviation Medication Transparency Act of 2025 seeks to enhance the clarity and accessibility of information regarding medications that are approved for use by pilots and air traffic controllers. The main goal is to help these aviation professionals and those training to become certified recognize which medications they can safely use without jeopardizing their medical certification.
Key Provisions
The bill includes several important points:
- Publication of Approved Medications: Within one year after the bill is enacted, the Federal Aviation Administration (FAA) Administrator must publish a list of medications that are deemed safe for airmen and air traffic control specialists. This list will be accessible on the FAA's public website.
- Consultation in Drafting the List: The list must be created with input from various stakeholders, including:
- The Aeromedical Innovation and Modernization Working Group
- Accredited higher education institutions in aviation
- Certified bargaining representatives for air traffic controllers
- Organizations representing airline pilots
- Other relevant stakeholders as identified by the Working Group
- Inclusivity of Medications: The list will cover all medications approved by the FAA, including both prescription and over-the-counter drugs.
- User-Friendly Format: Information must be presented in a clear and understandable way, especially for new applicants seeking medical certification. This includes indicating any required stabilization periods on specific medications.
- 'Do Not Issue' Medications: The list will also highlight medications designated as 'Do Not Issue' by the FAA, which means these should not be taken by individuals looking to maintain their medical certification.
- Contact Information for Medical Providers: The FAA will provide a means for medical providers to reach out with inquiries regarding the list of approved medications.
- Annual Updates: The FAA must review and update the medication list at least once a year to ensure it remains current.
This legislation aims to improve transparency regarding the use of medications in the aviation field, ultimately aiding in the safety and well-being of both airmen and air traffic controllers.
Relevant Companies
None found.
This is an AI-generated summary of the bill text. There may be mistakes.
Sponsors
4 bill sponsors
Actions
2 actions
| Date | Action |
|---|---|
| Nov. 20, 2025 | Introduced in Senate |
| Nov. 20, 2025 | Read twice and referred to the Committee on Commerce, Science, and Transportation. |
Corporate Lobbying
0 companies lobbying
None found.
* Note that there can be significant delays in lobbying disclosures, and our data may be incomplete.
Potentially Relevant Congressional Stock Trades
No relevant congressional stock trades found.